On the recordApril 24, 2013
I would hope--and I will conclude, Mr. Chairman--that the FDA would consider prioritizing its oversight.
Source
congress.govEditor's note · Context
Lowey urges the FDA to prioritize oversight of high-risk compounded products.
Share
More from Nita Lowey
Oct 1, 2020
I have a motion at the desk. The SPEAKER pro tempore. The Clerk will designate the motion. The text of the motion is as follows: Mrs. Lowey moves that the House concur in the Senate amendment to the title of H.R. 925 and that the House…
Oct 1, 2020
I am very pleased to yield 5 minutes to the distinguished gentleman from New Jersey (Mr. Pallone), the chairman of the Committee on Energy and Commerce, a member of my class in the Congress.
Jul 23, 2020
And I claim time in opposition. There are many things in this en bloc that I oppose, and I could speak to each issue, but I want to reserve my comments for the attack on climate change. Most of us, even my friends across the aisle, agree…
Oct 1, 2020
I am pleased to yield 5 minutes to the distinguished gentleman from Virginia (Mr. Scott), the chairman of the Committee on Education and Labor.
Other voices in this conversation
